| aiSLE® DX Flare Risk Index (Powered by LiquidFlareRisk™ Technology) |
Lupus (SLE) |
|
|
|
|
| aiSLE® DX Classification |
Lupus (SLE) |
|
|
|
|
| aiSLE® DX Disease Activity (Powered By LiquidDiseaseActivity™ Technology) |
Lupus (SLE) |
|
|
|
|
| aiSLE® DX Digital Biomarker |
Lupus (SLE) |
|
|
|
|
| aiMS™ DX Relapse Prediction |
Multiple Sclerosis (MS) |
|
|
|
|
| aiMS™ DX NMO Distinction |
Neuromyelitis Optica (NMO) |
|
|
|
|
| aiMS™ DX Disease Activity |
Multiple Sclerosis (MS) |
|
|
|
|
| aiMS™ DX Interferon Treatment Response |
Multiple Sclerosis (MS) |
|
|
|
|
| aiMS™ DX Digital Biomarker |
Multiple Sclerosis (MS) |
|
|
|
|
| To be determined |
Sjögren's Syndrome |
|
|
|
|
| Digital Biomarker |
Crohn's Disease / Ulcerative Colitis |
|
|
|
|
| Biologic Biomarkers |
Crohn's Disease / Ulcerative Colitis |
|
|
|
|
